Abnormal expression of proteoglycans in Ullrich's disease with collagen VI deficiency

Muscle Nerve. 2006 Jan;33(1):120-6. doi: 10.1002/mus.20449.

Abstract

Patients with Ullrich's disease have generalized muscle weakness, multiple contractures of the proximal joints, and hyperextensibility of the distal joints. Recently we found a marked reduction of fibronectin receptors in the skin and cultured fibroblasts of two patients with Ullrich's disease with collagen VI deficiency, and speculated that an abnormality of cell adhesion may be involved in the pathogenesis of the disease. In this study, we investigated the expression of proteoglycans and adhesion molecules in Ullrich's disease and other muscle diseases. We found a reduction of NG2 proteoglycan in the membrane of skeletal muscle but not in the skin in Ullrich's disease. By contrast, we found the upregulation of tenascin C in the extracellular matrix of skeletal muscle in Ullrich's disease. Our findings suggest that abnormal expression of proteoglycans and adhesion molecules may be involved in the pathogenesis of the dystrophic muscle changes in Ullrich's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens / analysis
  • Antigens / genetics
  • Antigens / metabolism*
  • Cell Membrane / chemistry
  • Collagen Type VI / deficiency*
  • Collagen Type VI / genetics
  • Down-Regulation
  • Extracellular Matrix / chemistry
  • Extracellular Matrix / metabolism
  • Frameshift Mutation
  • Humans
  • Male
  • Muscle, Skeletal / chemistry
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Muscular Dystrophies / genetics
  • Muscular Dystrophies / metabolism*
  • Muscular Dystrophies / pathology
  • Proteoglycans / analysis
  • Proteoglycans / genetics
  • Proteoglycans / metabolism*
  • Skin / chemistry
  • Skin / metabolism
  • Syndrome
  • Tenascin / analysis
  • Tenascin / metabolism*
  • Up-Regulation

Substances

  • Antigens
  • Collagen Type VI
  • Proteoglycans
  • Tenascin
  • chondroitin sulfate proteoglycan 4